プログラム |
|
|
|
|
| 4th March 2023 |
| 13:00-13:05 Opening Remarks |
|
| 13:05-14:05 Oral Session 1 (Neurobiology) |
| Chair: Takako Yasuda (Japan Women’s University, Japan) |
| OS1-1 |
Epidermal growth factor (EGF) signal modulates perineuronal net formation in the neocortex of developing rodent brains |
| Yuriko Iwakura (Niigata University Brain Research Institute, Japan) |
|
| OS1-2 |
A trial to control microglial activation in irradiated medaka embryo as a model to suppress prolonged inflammation in CNS |
| Takako Yasuda (Japan Women’s University, Japan) |
|
| OS1-3 |
High-throughput phenotypic assay using frozen neurons |
| Ayaka Higa (AlzMed, Inc., Japan) |
|
| OS1-4 |
Quantitative analysis for drebrin clusters along dendrites using immunocytochemical images of cultured rat hippocampal neurons |
| Shogo Mase (The University of Tokyo, Japan/Gunma University, Japan) |
|
14:05-14:15 Break |
|
| 14:15-15:15 Plenary Lecture |
| Chair: Yuko Sekino (The University of Tokyo, Japan) |
| PL1 |
Drebrin: from structure and function to physiological and pathological roles |
| Tomoaki Shirao (AlzMed, Inc., CEO, Japan) |
|
15:15-15:25 Break |
|
| 15:25-16:55 Oral Session 2(New Brain Tumor Treatments) |
| Chair: Shogo Ishiuchi (University of the Ryukyus, Japan) |
| OS2-1 |
Epigenetic upregulation of Schlafen11 renders WNT- and SHH- activated medulloblastomas sensitive to cisplatin |
| Satoshi Nakata(Johns Hopkins University School of Medicine, USA/Gunma University, Japan) |
|
| OS2-2 |
SLFN11 as a biomarker for sensitivity to radiation in medulloblastoma |
| Manabu Natsumeda (Niigata University, Japan) |
|
| OS2-3 |
Investigation of anti-tumor effects by inhibiting glucose uptake via sodium-glucose transporter 2 (SGLT2) expressed in glioblastoma cell lines |
Takeyoshi Eda (Brain Research Institute, Niigata University, Japan)
Chair: Yoshihiro Tsukamoto (Niigata University, Japan) |
|
| OS2-4 |
Therapeutic targeted surface antigen expression in choroid plexus carcinoma cell |
| Nobuhiro Kubo (Niigata University, Japan) |
|
| OS2-5 |
Near-infrared photoimmunotherapy using a small protein mimetic for brain metastasis of HER2-overexpressing breast cancer |
| Haruka Takezawa-Yamaguchi (The Nippon Dental University, Japan) |
|
| OS2-6 |
Near-infrared Photoimmunotherapy for Malignant Brain Tumors Targeting Podoplanin |
| Jotaro On (Niigata University, Japan) |
|
16:55-17:05 Break |
|
| 17:05-18:05 Keynote Lecture |
| Chair: Manabu Natsumeda (Niigata University, Japan) |
| KL1 |
Vulnerability of CA3 -Mossy fiber networks by radiation induces dysfunction of pattern separation and pattern completion |
| Shogo Ishiuchi (University of the Ryukyus, Japan) |
|
| KL2 |
Ground simulation experiment: Chromosome aberration frequencies due to space radiation exposure on the Moon and Mars |
| Akihisa Takahashi (Gunma University Heavy Ion Medical Center, Japan) |
|
Board Meeting |
|
| 5th March 2023 |
| 9:00-10:00 Oral Session 3 (Radiation Therapy) |
| Chair: Yoshiyuki Suzuki (Fukushima Medical University, Japan) |
| OS3-1 |
Unusual gustatory perception during radiotherapy sessions: a case report |
| Kazuma Umemiya (Fukushima Medical University, Japan) |
|
| OS3-2 |
Cognitive function of 3-year survivors after whole-brain radiotherapy for brain metastasis |
| Toshimichi Nakano (Niigata University, Japan) |
|
| OS3-3 |
Is re-radiation therapy appropriate for radiation induced glioma occurred post germinoma treatment? Two illustrative cases and literature review |
| Yoshihiro Tsukamoto (Niigata University, Japan) |
|
| OS3-4 |
Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy |
| Natsuko Kondo (Kyoto University, Japan) |
|
10:00-11:00 Oversea Lecture |
| Chair: Katsuyuki Shirai (Jichi Medical University Hospital, Japan) |
| OL |
Scientific and clinical requirements for FLASH therapy |
| Gael Boivin (Varian Medical Systems, Inc., Switzerland) |
|
11:00-11:10 Break |
|
| 11:10-12:10 Plenary Lecture |
| Chair: Nobuyuki Takei (Niigata University, Japan) |
| PL2 |
The Watershed between the Aging and Diseased Brain |
| Hitoshi Shimada (Niigata University, Japan) |
|
12:10-12:15 Closing Remark |
|
|
